MicroRNA-regulated feed forward loop network

由 Cohen, Ezra E.W., Rosner, Marsha Rich
發表在 Cell Cycle (2009)

New Strategies in Head and Neck Cancer: epidermal growth factor receptor inhibition in head and neck cancer

由 Chen, Lucy F., Cohen, Ezra E.W., Grandis, Jennifer R.
出版 2010

Modifiable Risk Behaviors in Head and Neck Cancer Patients

由 Sivasithamparam, Janani, Visk, Carly A., x Cohen, Ezra E. W. Cohen, King, Andrea C.
出版 2013

Leveraging TCR affinity in adoptive immunotherapy against shared tumor/self antigens

由 Miller, Aaron M., Bahmanof, Milad, Zehn, Dietmar, Cohen, Ezra E. W., Schoenberger, Stephen P.
發表在 Cancer Immunol Res (2018)

A Novel Peptide for Simultaneously Enhanced Treatment of Head and Neck Cancer and Mitigation of Oral Mucositis

由 Chen, Peili, Mancini, Maria, Sonis, Stephen T., Fernandez-Martinez, Juan, Liu, Jing, Cohen, Ezra E. W., Toback, F. Gary
發表在 PLoS One (2016)

Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy

由 Maggiore, Ronald J., Curran, Emily K., Witt, Mary Ellyn, Haraf, Daniel J., Vokes, Everett E., Cohen, Ezra E.W.
發表在 J Geriatr Oncol (2013)

The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patients

由 Ramírez, Jacqueline, Wu, Kehua, Janisch, Linda, Karrison, Theodore, House, Larry K., Innocenti, Federico, Cohen, Ezra E. W., Ratain, Mark J.
出版 2011

Study of Functional Infrared Imaging for Early Detection of Mucositis in Locally Advanced Head and Neck Cancer Treated With Chemoradiotherapy

由 Cohen, Ezra E.W., Ahmed, Omar, Kocherginsky, Masha, Shustakova, Galyna, Kistner-Griffin, Emily, Salama, Joseph K., Yefremenko, Volodymyr, Novosad, Valentyn
出版 2013

Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy

由 Boero, Isabel J., Paravati, Anthony J., Xu, Beibei, Cohen, Ezra E.W., Mell, Loren K., Le, Quynh-Thu, Murphy, James D.
發表在 J Clin Oncol (2016)

p62/SQSTM1 Accumulation in Squamous Cell Carcinoma of Head and Neck Predicts Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitors

由 Kuo, Wen-Liang, Sharifi, Marina N., Lingen, Mark W., Ahmed, Omar, Liu, Jing, Nagilla, Madhavi, Macleod, Kay F., Cohen, Ezra E. W.
出版 2014

Single Sample Expression-Anchored Mechanisms Predict Survival in Head and Neck Cancer

由 Yang, Xinan, Regan, Kelly, Huang, Yong, Zhang, Qingbei, Li, Jianrong, Seiwert, Tanguy Y., Cohen, Ezra E. W., Xing, H. Rosie, Lussier, Yves A.
出版 2012

Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo

由 Young, Natalie R., Soneru, Christian, Liu, Jing, Grushko, Tatyana A., Hardeman, Ashley, Olopade, Olufunmilayo I., Baum, Anke, Solca, Flavio, Cohen, Ezra E. W.
發表在 Target Oncol (2015)

Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, p...

由 Brose, Marcia S, Cabanillas, Maria E, Cohen, Ezra E W, Wirth, Lori J, Riehl, Todd, Yue, Huibin, Sherman, Prof Steven I, Sherman, Eric J
發表在 Lancet Oncol (2016)

A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy

由 Guram, Kripa, Kim, Sangwoo S., Wu, Victoria, Sanders, P. Dominick, Patel, Sandip, Schoenberger, Stephen P., Cohen, Ezra E. W., Chen, Si-Yi, Sharabi, Andrew B.
發表在 Front Immunol (2019)

Aspiration pneumonia after concurrent chemoradiotherapy for head-and-neck cancer

由 Xu, Beibei, Boero, Isabel J., Hwang, Lindsay, Le, Quynh-Thu, Moiseenko, Vitali, Sanghvi, Parag R., Cohen, Ezra E. W., Mell, Loren K., Murphy, James D.
發表在 Cancer (2014)

Immune modulation of head and neck squamous cell carcinoma and the tumor microenvironment by conventional therapeutics

由 Miyauchi, Sayuri, Kim, Sangwoo S., Pang, John, Gold, Kathryn A., Gutkind, J. Silvio, Califano, Joseph A., Mell, Loren K., Cohen, Ezra E. W., Sharabi, Andrew B.
發表在 Clin Cancer Res (2019)

Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition

由 Young, Natalie R., Liu, Jing, Pierce, Carolyn, Wei, Tai-Fen, Grushko, Tatyana, Olopade, Olufunmilayo I., Liu, Wanqing, Shen, Christine, Seiwert, Tanguy Y., Cohen, Ezra E.W.
出版 2012

HPV16 E5 Mediates Resistance to PD-L1 Blockade and can be targeted with Rimantadine in Head and Neck Cancer

由 Miyauchi, Sayuri, Sanders, P. Dominick, Guram, Kripa, Kim, Sangwoo S., Paolini, Francesca, Venuti, Aldo, Cohen, Ezra E. W., Gutkind, J. Silvio, Califano, Joseph A., Sharabi, Andrew B.
發表在 Cancer Res (2019)

Prognostic Role of p16 in Nonoropharyngeal Head and Neck Cancer

由 Bryant, Alex K, Sojourner, Elena J, Vitzthum, Lucas K, Zakeri, Kaveh, Shen, Hanjie, Nguyen, Cammie, Murphy, James D, Califano, Joseph A, Cohen, Ezra E W, Mell, Loren K
發表在 J Natl Cancer Inst (2018)

B-cells improve overall survival in HPV-associated squamous cell carcinomas and are activated by radiation and PD-1 blockade.

由 Kim, Sangwoo Shawn, Shen, Sarek, Miyauchi, Sayuri, Sanders, Philip Dominick, Franiak-Pietryga, Ida, Mell, Loren K., Gutkind, J. Silvio, Cohen, Ezra E.W., Califano, Joseph, Sharabi, Andrew B.
發表在 Clin Cancer Res (2020)